← Back to Search

Cognitive Stimulation Therapy for Dementia

N/A
Waitlist Available
Led By Michael Lepore, PhD
Research Sponsored by University of Massachusetts, Amherst
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Mild Cognitive Impairment or Mild to Moderate Dementia
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will determine if V-CST can help people with mild to moderate dementia, by comparing cognitive decline between those who participate in V-CST and those who don't.

Who is the study for?
This trial is for English-speaking individuals with mild to moderate dementia, as indicated by certain cognitive test scores. They must have a scheduled visit for cognitive screening within 6-12 months and not have participated in V-CST before. Those without online access or necessary caregiver support, or who have impairments that interfere with group therapy are excluded.Check my eligibility
What is being tested?
The trial tests if Cognitive Stimulation Therapy (CST) delivered virtually can slow down cognitive decline in dementia patients compared to standard care. Participants will be randomly assigned to either receive a referral for virtual CST or continue with their usual treatment without changes.See study design
What are the potential side effects?
Since the intervention involves non-pharmacological therapy, traditional side effects associated with medications are not expected. However, participants may experience discomfort from using technology or feelings of frustration if they find the sessions challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with mild cognitive impairment or mild to moderate dementia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cognitive decline measured by an increase in Montreal Cognitive Assessment Score from baseline to follow-up
Secondary outcome measures
Cognitive improvement measured by a decrease in Montreal Cognitive Assessment Score from baseline to follow-up
Participant Attrition
Participant attendance
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Referral for Cognitive Stimulation TherapyActive Control1 Intervention
This group will receive a referral from their physician for CST treatment
Group II: Standard of CarePlacebo Group1 Intervention
This group will receive standard of care and no CST referral.

Find a Location

Who is running the clinical trial?

University of Massachusetts, AmherstLead Sponsor
78 Previous Clinical Trials
467,639 Total Patients Enrolled
UConn HealthOTHER
211 Previous Clinical Trials
60,488 Total Patients Enrolled
Yale UniversityOTHER
1,848 Previous Clinical Trials
2,737,685 Total Patients Enrolled

Media Library

Cognitive Stimulation Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05860127 — N/A
Mild Cognitive Impairment Research Study Groups: Standard of Care, Referral for Cognitive Stimulation Therapy
Mild Cognitive Impairment Clinical Trial 2023: Cognitive Stimulation Therapy Highlights & Side Effects. Trial Name: NCT05860127 — N/A
Cognitive Stimulation Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05860127 — N/A
Mild Cognitive Impairment Patient Testimony for trial: Trial Name: NCT05860127 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions in this trial for participants?

"According to the details visible on clinicaltrials.gov, this experiment is not presently in need of participants. Having been initially posted on June 15th 2023 and last updated May 12th 2023, there are no active recruitment efforts for this trial at present. Nonetheless, there are 1,201 other experiments actively looking for volunteers right now."

Answered by AI

Who else is applying?

What state do they live in?
Connecticut
What site did they apply to?
Yale Memory Clinic
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

My mind is going and I'm only 40 I need help!!!
PatientReceived no prior treatments

What questions have other patients asked about this trial?

What are you going to do to me?
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial
Michael Lepore 2023. "Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05860127.
All > Semantic Dementia > Frontotemporal Dementia
~19 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top